They can include nirmatrelvir-ritonavir (Paxlovid), remdesivir (Veklury) or molnupiravir (Lagevrio). Paxlovid combines two medicines. The first, called nirmatrelvir, blocks the activity of an ...

The antiviral drug molnupiravir (Lagevrio) slashed the risk of death from COVID-19 in half when given early to older adults.

Merck and Ridgeback Biotherapeutics begin phase 3 MOVe-NOW trial of Lagevrio for the treatment of Covid-19 in high-risk adults: Rahway, New Jersey Saturday, December 7, 2024, 12:0 ...

Merck (MRK) announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate Lagevrio, an investigational oral antiviral COVID-19 ...

US advisers will meet on 30 November to review the drug's safety and efficacy data and vote on whether molnupiravir should be authorized. The pill, which will be branded as Lagevrio in Britain ...

According to the paper, Health Secretary Sajid Javid is preparing to announce the beginning of a national pilot of Lagevrio, also known as molnupiravir. The love life of a contestant on the I'm a ...

Health Secretary Sajid Javid is said to be preparing to announce a national pilot of Lagevrio, also known as molnupiravir, the so-called "game-changing" pill that the UK became the first country ...

The 25,000-subject PANORAMIC trial conducted by researchers at Oxford University looked at the addition of a five-day course of Lagevrio (molnupiravir) to standard care in people aged over 50 ...

People with acute COVID-19 who took the antiviral drug molnupiravir (Lagevrio) reported modest improvements in symptoms, less ...

Lagevrio (molnupiravir) added $3.2 billion to Merck's top line of $15.9 billion, but even without the drug sales would have risen 19% thanks to a strong performance from cancer immunotherapy ...